Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,854    

Indirect Shares

   247,533      
Direct Value   $43,056,670    

Indirect Value

   $21,938,850      
Total Shares   787,387      
Total Value   $64,995,519      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $22,570 Incyte Corp $887,749 Immunome Inc. $141,437
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
* Premium Members only  

Records found :    852         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 21 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-23 4 AS $82.58 $825,811 D/D (10,000) 290,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-24 4 AS $82.29 $822,887 D/D (10,000) 290,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-24 4 OE $38.59 $385,900 D/D 10,000 300,031 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-04-30 4 A $68.78 $21,254 D/D 309 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-10 4 AS $89.59 $1,679,794 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-10 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-11 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-11 4 AS $88.42 $1,657,856 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-14 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-14 4 AS $89.22 $1,672,851 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-15 4 AS $88.29 $1,655,434 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-15 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-16 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-16 4 AS $89.13 $1,671,131 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-17 4 OE $38.59 $723,563 D/D 18,750 309,350 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-17 4 AS $88.66 $1,662,356 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-06-04 4 D $92.07 $580,962 D/D (6,310) 284,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-06-13 4 OE $14.39 $14,390 D/D 1,000 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-07-23 4 AS $101.69 $152,535 D/D (1,500) 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-07-23 4 OE $17.86 $26,790 D/D 1,500 286,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-04 4 OE $17.86 $26,790 D/D 1,500 286,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-04 4 AS $98.16 $147,240 D/D (1,500) 285,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-09-25 4 OE $14.39 $14,390 D/D 1,000 286,290 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-10-03 4 OE $17.86 $26,790 D/D 1,500 287,790 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-10-03 4 AS $99.36 $149,040 D/D (1,500) 286,290 0 -
  852  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21  22   23   24   25   26   27   28   29   30   31   32   33   34   35      
  Page 21 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us